Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes

Journal of Clinical Oncology

Volumn 28, Issue 17, 2010, Pages 2868-2873

  Andersson, Yvette ^a   Frisell, Jan ^a   Sylvan, Maria ^a   De Boniface, Jana ^a   Bergkvist, Leif ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; AXILLA; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; LYMPH NODE; LYMPHADENECTOMY; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

AXILLA; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77956415767     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.5001     Document Type: Article

References (25)

1. Maaskant AJ, van de Poll-Franse LV, Voogd AC, et al: Stage migration due to introduction of the sentinel node procedure: A population-based study. Breast Cancer Res Treat 113:173-179, 2009
2. Madsen AH, Jensen AR, Christiansen P, et al: Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group. Acta Oncol 47:239-247, 2008
3. van der Heiden-van der Loo M, Bezemer PD, Hennipman A, et al: Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32:710-714, 2006 (Pubitemid 44276004)
4. Colleoni M, Rotmensz N, Peruzzotti G, et al: Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379-1389, 2005
5. Cox CE, Kiluk JV, Riker AI, et al: Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206:261-268, 2008
6. Millis RR, Springall R, Lee AH, et al: Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 86:396-401, 2002 (Pubitemid 34185124)
7. Nasser IA, Lee AK, Bosari S, et al: Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 24:950-957, 1993
8. Tan LK, Giri D, Hummer AJ, et al: Occult axillary node metastases in breast cancer are prognostically significant: Results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26:1803-1809, 2008
9. Truong PT, Vinh-Hung V, Cserni G, et al: The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44:1670-1677, 2008
10. Wada N, Imoto S: Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol 13:24-32, 2008 (Pubitemid 351326290)
11. de Boer M, van Deurzen CH, van Dijck JA, et al: Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653-663, 2009
12. Grabau D, Jensen MB, Rank F, et al: Axillary lymph node micrometastases in invasive breast cancer: National figures on incidence and overall survival. APMIS 115:828-837, 2007 (Pubitemid 47030098)
13. Fant JS, Grant MD, Knox SM, et al: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126-130, 2003 (Pubitemid 40485931)
14. Gobardhan PD, Elias SG, Madsen EV, et al: Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: A cohort study. Ann Oncol 20:41-48, 2009
15. Herbert GS, Sohn VY, Brown TA: The impact of nodal isolated tumor cells on survival of breast cancer patients. Am J Surg 193:571-574, 2007 (Pubitemid 46559901)
16. Hwang RF, Gonzalez-Angulo AM, Yi M, et al: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110:723-730, 2007 (Pubitemid 47257646)
17. Nagashima T, Sakakibara M, Nakano S, et al: Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer 13:186-191, 2006
18. Bergkvist L, de Boniface J, Jonsson PE, et al: Axillary recurrence rate after negative sentinel node biopsy in breast cancer: Three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg 247:150-156, 2008
19. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002 (Pubitemid 34983222)
20. Kuijt GP, Voogd AC, van de Poll-Franse LV, et al: The prognostic significance of axillary lymphnode micrometastases in breast cancer patients. Eur J Surg Oncol 31:500-505, 2005 (Pubitemid 40724091)
21. Cummings MC, Walsh MD, Hohn BG, et al: Occult axillary lymph node metastases in breast cancer do matter: Results of 10-year survival analysis. Am J Surg Pathol 26:1286-1295, 2002
22. Cote RJ, Peterson HF, Chaiwun B, et al: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer: International Breast Cancer Study Group. Lancet 354:896-900, 1999 (Pubitemid 29424019)
23. Cserni G, Sapino A, Decker T: Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15:347-354, 2006 (Pubitemid 43812223)
24. Connolly JL: Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th Edition, for breast cancer. Arch Pathol Lab Med 130:287-291, 2006
25. Rutgers EJ: Sentinel node biopsy: Interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26:698-702, 2008